Search Results 2621-2630 of 18726 for ectopic-pregnancy

1. Phase 1/2a Clinical Trial Of PR001 (LY3884961) In Patients With Parkinson's Disease With At Least One GBA1 Mutation (PROPEL)

   Women of childbearing potential cannot be pregnant or lactating/breastfeeding and must have a negative result for serum pregnancy test at Screening. Patient ...

2. Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia - Mayo Clinic

   * Pregnancy. All female patients with reproductive potential must have a negative pregnancy test (serum or urine) within the screening period prior to start ...

3. Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer

   Pregnant or nursing women; Women of child-bearing potential, unless they are using highly effective methods of contraception; Sexually active males unless ...

4. A Study to Evaluate the Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia with Lewy Bodies - Mayo Clinic

   ... pregnancy test result during Screening and/or is unwilling or unable to adhere to the contraception requirements specified in the protocol. Participating ...

5. Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology - Mayo Clinic

   The subject is of childbearing potential and is, or plans to become pregnant during the time of the study (method of assessment upon study physician's ...

6. Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma - Mayo Clinic

   Female patients who are breastfeeding or pregnant; Coexistent second malignancy or history of prior solid organ malignancy within previous 3 years; Serious ...

7. A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202) - Mayo Clinic

   8. Female patients who are pregnant or breast-feeding. 9. Prior malignancies except resected basal cell carcinoma or treated cervical carcinoma in situ. 10 ...

8. Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS - Mayo Clinic

   Pregnancy/breast feeding; Drug abuse. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date ...

9. A Randomized, Open-label Two-arm Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy after Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma - Mayo Clinic

   Primary mediastinal large B cell lymphoma is treated with a combination of chemotherapy and the monoclonal antibody rituximab (chemoimmunotherapy). Following ...

10. Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer - Mayo Clinic

    Women of child-bearing potential must have negative serum pregnancy test within 14 days prior to randomization and must not be breast feeding; Participation ...